Prosecution Insights
Last updated: April 19, 2026

Examiner: WILLIAMS, CATHERINE SERKE

Tech Center 3900 • Art Units: 3993

This examiner grants 66% of resolved cases

Performance Statistics

66.4%
Allow Rate
+6.4% vs TC avg
142
Total Applications
+26.4%
Interview Lift
1130
Avg Prosecution Days
Based on 116 resolved cases, 2023–2026

Rejection Statute Breakdown

2.1%
§101 Eligibility
18.6%
§102 Novelty
34.2%
§103 Obviousness
25.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18206215 METHODS AND APPARATUS FOR AN ADJUSTABLE STIFFNESS CATHETER Non-Final OA W. L. Gore & Associates, Inc.
17988830 An instrument for endoscopic applications or the like Non-Final OA Fortimedix Assets II B.V
18421864 METHODS OF TREATING CELLULITE AND SUBCUTANEOUS ADIPOSE TISSUE Non-Final OA Soliton, Inc.
17961249 METHODS AND APPARATUSES FOR PERITONEAL CATHETER PLACEMENT Final Rejection Baxter Healthcare SA
18745670 MICROCATHETER OCCLUSION EMBOLIZATION CATHETER Non-Final OA Merit Medical Systems, Inc.
18741653 ANTIBIOTIC DELIVERY SYSTEM AND METHOD FOR TREATING AN INFECTED SYNOVIAL JOINT DURING RE-IMPLANTATION OF AN ORTHOPEDIC PROSTHESIS Non-Final OA Osteal Therapeutics, Inc.
18672890 ORTHODONTIC APPLIANCE INCLUDING ARCH MEMBER Non-Final OA Brius Technologies, Inc.
18212744 Systems and Methods for Sinus Access Non-Final OA Intersect ENT International GmbH
18499936 PORTABLE LOWER LIMB THERAPY DEVICE Non-Final OA Physiohab LLC
18288850 Microneedle Based Delivery System Non-Final OA Latch Medical Limited
18277383 DEVICE FOR FLOW DETECTION OF MOTHER'S MILK Non-Final OA KAIZEN BIO-TECH (2011) LTD.
17864363 EXPANDABLE INTERVERTEBRAL CAGE ASSEMBLIES Final Rejection Spectrum Spine IP Holdings, LLC
18025459 DEVICES AND METHODS FOR CONTINUOUS EXTRUSION OF A DRUG INTO THE MOUTH Non-Final OA SynAgile Corporation
17894780 PERIPHERAL VISUAL TRAINER AND PERIPHERAL VISUAL TRAINING SYSTEM Final Rejection PERCEPTIVE SPORT TECHNOLOGIES, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month